A Second-Generation MicroRNA-Based Assay for Diagnosing Tumor Tissue Origin

Abstract excerpt

BACKGROUND: Cancers of unknown primary origin (CUP) constitute 3%-5% (50,000 to 70,000 cases) of all newly diagnosed cancers per year in the United States. Including cancers of uncertain primary origin, the total number increases to 12%-15% (180,000 to 220,000 cases) of all newly diagnosed cancers per year in the United States. Cancers of unknown/uncertain primary origins present major diagnostic and clinical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Diagnosis and Treatment
• Share to Head and Neck Cancer Studies
• Share to Oral Health Pathology and Treatment